Cargando…
Development of a Pemetrexed/Folic Acid Nanoformulation: Synthesis, Characterization, and Efficacy in a Murine Colorectal Cancer Model
[Image: see text] The folate analogue pemetrexed (PEM) is an approved therapeutic for non-small cell lung cancer and malignant pleural mesothelioma with the potential for broader application in combination therapies. Here, we report the development of a nanoformulation of PEM and its efficacy agains...
Autores principales: | Rosch, Justin G., DuRoss, Allison N., Landry, Madeleine R., Sun, Conroy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331029/ https://www.ncbi.nlm.nih.gov/pubmed/32637817 http://dx.doi.org/10.1021/acsomega.0c01550 |
Ejemplares similares
-
Formulation of Folate-Modified Raltitrexed-Loaded Nanoparticles for Colorectal Cancer Theranostics
por: Rosch, Justin G., et al.
Publicado: (2020) -
Nanoalginates via Inverse-Micelle Synthesis: Doxorubicin-Encapsulation and Breast Cancer Cytotoxicity
por: Rosch, Justin G., et al.
Publicado: (2018) -
Preclinical data on co-delivery of temozolomide and talazoparib by fucodain-coated nanoscale metal organic frameworks for colorectal cancer chemoradiation
por: DuRoss, Allison N., et al.
Publicado: (2021) -
Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy
por: Landry, M.R., et al.
Publicado: (2020) -
Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers
por: Landry, Madeleine, et al.
Publicado: (2022)